AU6522900A - Hepatitis a virus clones adapted for growth in african green monkey kidney (agmk) cells and vaccines comprising said clones - Google Patents

Hepatitis a virus clones adapted for growth in african green monkey kidney (agmk) cells and vaccines comprising said clones

Info

Publication number
AU6522900A
AU6522900A AU65229/00A AU6522900A AU6522900A AU 6522900 A AU6522900 A AU 6522900A AU 65229/00 A AU65229/00 A AU 65229/00A AU 6522900 A AU6522900 A AU 6522900A AU 6522900 A AU6522900 A AU 6522900A
Authority
AU
Australia
Prior art keywords
clones
agmk
vaccines
hepatitis
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65229/00A
Inventor
Suzanne U Emerson
Robert H. Purcell
Gopa Raychaudhuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU6522900A publication Critical patent/AU6522900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32441—Use of virus, viral particle or viral elements as a vector
    • C12N2770/32443—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32461—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU65229/00A 1999-08-06 2000-08-04 Hepatitis a virus clones adapted for growth in african green monkey kidney (agmk) cells and vaccines comprising said clones Abandoned AU6522900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14763799P 1999-08-06 1999-08-06
US60/147637 1999-08-06
PCT/US2000/021429 WO2001011065A2 (en) 1999-08-06 2000-08-04 Hepatitis a virus clones adapted for growth in agmk cells

Publications (1)

Publication Number Publication Date
AU6522900A true AU6522900A (en) 2001-03-05

Family

ID=22522319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65229/00A Abandoned AU6522900A (en) 1999-08-06 2000-08-04 Hepatitis a virus clones adapted for growth in african green monkey kidney (agmk) cells and vaccines comprising said clones

Country Status (2)

Country Link
AU (1) AU6522900A (en)
WO (1) WO2001011065A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
EP3695849A1 (en) * 2019-02-13 2020-08-19 Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH Method for extracting hepatitis a virus (hav) antigen from cell culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478746A (en) * 1982-04-07 1995-12-26 The United States Of America As Represented By The Department Of Health And Human Services cDNA encoding attenuated cell culture adapted hepatitis A virus genome
US4894228A (en) * 1982-04-07 1990-01-16 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus

Also Published As

Publication number Publication date
WO2001011065A2 (en) 2001-02-15
WO2001011065A3 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
GC0000202A (en) Combined vaccine composition comprising a hepatitis b viral (hbv) antigen and a human papillomavirus(hpv) antigen
SI1165126T1 (en) Process for preparing a human papillomavirus vaccine with disassembled and reassembled virus-like particles
AU4869299A (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
EP1292603B8 (en) Methods and compositions for treating hepatitis c virus
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2001295063A1 (en) A method for limiting the growth of cancer cells using an attenuated measles virus
GB2366295B (en) A device and methods for preparing undifferentiated cells
EP1322325A4 (en) Inhibiting hepatitis c virus processing and replication
AU2003206862A1 (en) Hepatitis b vaccines
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
AU5137800A (en) Cd4-independent hiv envelope proteins as vaccines and therapeutics
AU6029000A (en) Mosaic infectious bursal disease virus vaccines
AU2797799A (en) (in vitro) model for viral infection and immune response
AU7903100A (en) Peptide mixture and vaccine against a chronic viral infection
AU2002225895A1 (en) Hepatitis c virus constructs characterized by high efficiency replication
IL143798A0 (en) Hepatitis c virus ns3 protease
AU6522900A (en) Hepatitis a virus clones adapted for growth in african green monkey kidney (agmk) cells and vaccines comprising said clones
AU2292600A (en) Varicella-zoster virus vaccines
AU4529401A (en) Aids ancestral viruses and vaccines
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AU2001257505A1 (en) Hepatitis c virus helicase crystals, crystallographic structure and methods
HK1034202A1 (en) Combined vaccine against hepatitis a and hepatitisb
EP1490396A4 (en) Immunogenic hiv peptides for use as reagents and vaccines
AU2000252449A1 (en) Recombinant vaccines against infectious bursal disease virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase